liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Report and Recommendations of the Workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced Cardiotoxicity
JRC.
Boehringer Ingelheim Pharma GmbH & Co KG.
AstraZeneca R&D.
Novartis Institute Biomed Research.
Show others and affiliations
2009 (English)In: CARDIOVASCULAR TOXICOLOGY, ISSN 1530-7905, Vol. 9, no 3, 107-125 p.Article, review/survey (Other academic) Published
Abstract [en]

Cardiotoxicity is among the leading reasons for drug attrition and is therefore a core subject in non-clinical and clinical safety testing of new drugs. European Centre for the Validation of Alternative Methods held in March 2008 a workshop on "Alternative Methods for Drug-induced Cardiotoxicity" in order to promote acceptance of alternative methods reducing, refining or replacing the use of laboratory animals in this field. This review reports the outcome of the workshop. The participants identified the major clinical manifestations, which are sensitive to conventional drugs, to be arrhythmias, contractility toxicity, ischaemia toxicity, secondary cardiotoxicity and valve toxicity. They gave an overview of the current use of alternative tests in cardiac safety assessments. Moreover, they elaborated on new cardiotoxicological endpoints for which alternative tests can have an impact and provided recommendations on how to cover them.

Place, publisher, year, edition, pages
2009. Vol. 9, no 3, 107-125 p.
Keyword [en]
Alternative tests, Cardiotoxicity, Drugs, Arrhythmias, Contractility toxicity, Ischaemia toxicity, Secondary cardiotoxicity, Valve toxicity
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-20416DOI: 10.1007/s12012-009-9045-3OAI: oai:DiVA.org:liu-20416DiVA: diva2:234526
Available from: 2009-09-08 Created: 2009-09-07 Last updated: 2009-09-08

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Mandenius, Carl-Fredrik

Search in DiVA

By author/editor
Mandenius, Carl-Fredrik
By organisation
Biotechnology The Institute of Technology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 86 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf